China · Series D startup

Who invested in Akeso Biopharma

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$150Mraised across 1 round since 2019, from 1 source

Latest round
Series D, $150MNov 2019
Investors
2
See who backed them

The rounds

  1. Nov 2019
    Series D$150M

    Reported by DealStreetAsia

Everyone who backed them

Loyal Valley CapitalPrivate equity1round
Sino Biopharmno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Akeso Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Starbound VenturesVC firmPer its own site

Quick answers about Akeso Biopharma

Who invested in Akeso Biopharma?

Akeso Biopharma's investors include Loyal Valley Capital and Sino Biopharm.

How much has Akeso Biopharma raised?

Akeso Biopharma has raised $150M across 1 round since 2019.

When did Akeso Biopharma last raise?

Akeso Biopharma's most recent round was a Series D of $150M in Nov 2019.

What was Akeso Biopharma's biggest round?

Its most recent round, $150M in Nov 2019, is also its largest on record.

Who backed Akeso Biopharma first?

Akeso Biopharma's first round on record, in Nov 2019, was backed by Loyal Valley Capital and Sino Biopharm.

What stage is Akeso Biopharma at?

Akeso Biopharma's latest named round is a Series D, in Nov 2019.

Where is Akeso Biopharma based?

Akeso Biopharma is based in China.

Companies like Akeso Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.